Related Experiment Video
Updated: Aug 9, 2025

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer
Charlotte Zoe Angel1,2, Mei Yu Cynthia Stafford1, Christopher J McNally1
1Genomic Medicine Research Group, Ulster University, Cromore Road, Coleraine BT52 1SA, UK.
Hypoxia, or low oxygen, drives microRNA-21 (miR-21) over-expression in prostate cancer, promoting tumour progression by suppressing the RHOB gene. MiR-21 shows potential as a biomarker for hypoxia and prostate cancer outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tumour hypoxia is a known driver of prostate cancer progression.
- Hypoxia influences microRNA expression, but miR-21's role in hypoxic prostate tumours is unclear.
- MicroRNA-21 (miR-21) over-expression is linked to various cancers.
Purpose of the Study:
- To investigate the relationship between hypoxia and miR-21 in prostate cancer.
- To determine if hypoxia up-regulates miR-21 in prostate cancer cells and tumours.
- To explore miR-21's functional role and potential as a biomarker.
Main Methods:
- Bioinformatic analysis of The Cancer Genome Atlas (TCGA) prostate cancer datasets.
- In vitro studies using LNCaP prostate cancer cell lines.
- In vivo studies using prostate tumour xenograft models.
- Functional enrichment analysis and in silico validation.
Main Results:
- miR-21 up-regulation is significantly associated with prostate cancer and disease progression markers.
- Hypoxia was confirmed to cause miR-21 over-expression in vitro and in vivo.
- miR-21 promotes cell migration and colony formation, and down-regulates the tumour suppressor gene RHOB.
- miR-21 expression levels correlate with patient outcomes post-therapy.
Conclusions:
- Hypoxia is a key driver of miR-21 over-expression in prostate tumours.
- miR-21 promotes prostate cancer progression by suppressing RHOB.
- miR-21 holds significant potential as a diagnostic and prognostic biomarker for hypoxia and prostate cancer.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
MicroRNAs

